Erythema Multiforme News and Research

RSS
Erythema multiforme is a hypersensitivity disorder that mostly affects children and young adults, though it can affect people of any age. Erythema multiforme is part of a group of 3 related skin disorders and it is the mildest of the three. The other two more severe disorders are Stevens-Johnson syndrome and toxic epidermal necrolysis. Erythema multiforme is a very rare condition affecting males more than females.
FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Gleevec reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors

Gleevec reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors

Tissue-cultured smallpox vaccine shows promise

Tissue-cultured smallpox vaccine shows promise

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

FDA approves etravirine tablets for HIV

FDA approves etravirine tablets for HIV

New HIV drug will help millions

New HIV drug will help millions

FDA approves Acambis smallpox vaccine

FDA approves Acambis smallpox vaccine

Gleevec available to patients in post-surgical GIST study

Gleevec available to patients in post-surgical GIST study